[HTML][HTML] Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis

HF Escobar-Morreale, M Luque-Ramírez, F González - Fertility and sterility, 2011 - Elsevier
OBJECTIVE: To perform a review and metaanalysis of the studies evaluating the status of
serum inflammatory markers in women with polycystic ovary syndrome (PCOS). DESIGN …

The role of low-grade inflammation in the polycystic ovary syndrome

A Repaci, A Gambineri, R Pasquali - Molecular and cellular endocrinology, 2011 - Elsevier
PCOS is not only the most frequent cause of oligomenorrhea in young women, but also a
metabolic disorder characterized by insulin resistance, glucose intolerance, dyslipidemia …

Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome

KA Toulis, DG Goulis, G Mintziori… - Human reproduction …, 2011 - academic.oup.com
BACKGROUND The relation between polycystic ovary syndrome (PCOS) and
cardiovascular disease (CVD) remains unclear. In an attempt to provide high-quality …

PCOS Forum: research in polycystic ovary syndrome today and tomorrow

R Pasquali, E Stener‐Victorin, BO Yildiz… - Clinical …, 2011 - Wiley Online Library
Objective To summarize promising areas of investigation into polycystic ovary syndrome
(PCOS) and to stimulate further research in this area. Design Summary of a conference held …

Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS

J Puurunen, T Piltonen… - The Journal of …, 2011 - academic.oup.com
Context: Women with polycystic ovary syndrome (PCOS) are known to suffer from
hyperandrogenism and impaired glucose tolerance, as well as chronic inflammation …

Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS)

ME Solano, VA Sander, H Ho, AB Motta… - Journal of Reproductive …, 2011 - Elsevier
PCOS, a major cause of anovulatory sterility, is associated with obesity, insulin resistance
and chronic inflammation. New evidence suggests that the immune system aggravates the …

State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS)

DH Geller, D Pacaud, CM Gordon, M Misra… - International Journal of …, 2011 - Springer
PCOS, a heterogeneous disorder characterized by cystic ovarian morphology, androgen
excess, and/or irregular periods, emerges during or shortly after puberty. Peri-and post …

Polycystic ovary syndrome and the peripheral blood white cell count

AC Herlihy, RE Kelly, JL Hogan… - Journal of Obstetrics …, 2011 - Taylor & Francis
This retrospective cross-sectional study examined if the white cell count (WCC) is increased
in women with polycystic ovary syndrome (PCOS) and if so, is it due to PCOS or to the …

Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment

S Kilic, N Yilmaz, E Zulfikaroglu… - Gynecological …, 2011 - Taylor & Francis
Our aim was to evaluate the optimal treatment strategy addressing cardiovascular risk in
obese and nonobese patients with polycystic ovary syndrome (PCOS). We planned a …

The polycystic ovary syndrome (pcos) status and cardiovascular risk in young women

IR Ilie, CE Pepene, I Marian, T Mocan, G Hazi… - … European journal of …, 2011 - Springer
The study investigated the presence of early vascular damage and chronic inflammation,
and their relationships with hormonal and metabolic parameters in 45 young women with …